Jeff Baxter
Chief Executive Officer bij VBI VACCINES INC.
Vermogen: 12 225 $ op 31-03-2024
Actieve functies van Jeff Baxter
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VBI VACCINES INC. | Director/Board Member | 01-05-2016 | - |
| Chief Executive Officer | 01-05-2016 | - | |
| President | 01-05-2016 | - | |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Director/Board Member | 22-09-2009 | - |
| Chief Executive Officer | 22-09-2009 | - | |
| President | 22-09-2009 | - | |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Director/Board Member | 01-07-2014 | - |
| Chief Executive Officer | 01-07-2014 | - | |
| President | 01-07-2014 | - |
Loopbaan van Jeff Baxter
Eerdere bekende functies van Jeff Baxter
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CHROMADEX CORPORATION | Director/Board Member | 16-04-2015 | 04-04-2022 |
| Independent Dir/Board Member | 16-04-2015 | 04-04-2022 | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Chief Investment Officer | - | 28-02-2009 |
| Private Equity Investor | - | 28-02-2009 | |
| GSK PLC | Corporate Officer/Principal | 01-01-2002 | 01-07-2006 |
| UNILEVER PLC | Corporate Officer/Principal | - | - |
| BRITISH AMERICAN TOBACCO P.L.C. | Corporate Officer/Principal | - | - |
Opleiding van Jeff Baxter
| University of West London | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Verenigd Koninkrijk | 5 |
Operationeel
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectoraal
| Health Technology | 6 |
| Consumer Non-Durables | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| BRITISH AMERICAN TOBACCO P.L.C. | Consumer Non-Durables |
| UNILEVER PLC | Consumer Non-Durables |
| GSK PLC | Health Technology |
| CHROMADEX CORPORATION | Health Technology |
| VBI VACCINES INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Finance |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
- Beurs
- Insiders
- Jeff Baxter
- Ervaring
